Sellas Life Sciences Group Inc.
Featured video - SELLAS Reports Preliminary Data Showing Clinical[...]
Safety and Efficacy of Pegunigalsidase Alfa vs Agalsidase Beta on Renal[...]
Safety and efficacy of pegunigalsidase alfa vs agalsidase beta on renal[...]
01/27/2022 | Press release | Distributed by Public on 01/27/2022 05:10
Please select the service you want to use:
Smartlinks | Equinix Inc. | News | Education | Technology | Internet | Internet and Online Services | E-Commerce | Local News | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Shareholders | Business Announcement | Information Technology | Software | Retail | E-Commerce | Lifestyle and Leisure | Leisure | Public Companies | Hosting and Cloud Service Companies | London Stock Exchange (LSE) | Börse Frankfurt | Bolsa de Valores de São Paulo (B3) | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | Bolsa Mexicana de Valores (BMV) | BX Swiss | Tradegate Exchange | XETRA | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | BZX Exchange | Cboe Off Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | NYSE Chicago | Bolsa Institucional de Valores (BIVA)
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact